➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Johnson and Johnson
Harvard Business School
Dow
Baxter

Last Updated: May 12, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: CABERGOLINE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

CABERGOLINE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Ingenus Pharms Llc CABERGOLINE cabergoline TABLET;ORAL 204735 ANDA Ingenus Pharmaceuticals, LLC 50742-118-08 8 TABLET in 1 BOTTLE (50742-118-08) 2018-08-09
Ingenus Pharms Llc CABERGOLINE cabergoline TABLET;ORAL 204735 ANDA REMEDYREPACK INC. 70518-2379-0 8 POUCH in 1 BOX, UNIT-DOSE (70518-2379-0) > 1 TABLET in 1 POUCH (70518-2379-1) 2019-10-23
Ivax Sub Teva Pharms CABERGOLINE cabergoline TABLET;ORAL 077750 ANDA Teva Pharmaceuticals USA, Inc. 0093-5420-88 1 BOTTLE in 1 CARTON (0093-5420-88) > 8 TABLET in 1 BOTTLE 2007-03-07
Ivax Sub Teva Pharms CABERGOLINE cabergoline TABLET;ORAL 077750 ANDA A-S Medication Solutions 50090-3157-0 1 BOTTLE in 1 CARTON (50090-3157-0) > 8 TABLET in 1 BOTTLE 2007-03-07
Par Pharm CABERGOLINE cabergoline TABLET;ORAL 076310 ANDA Par Pharmaceutical, Inc. 49884-673-14 8 TABLET in 1 BOTTLE (49884-673-14) 2005-12-29
Par Pharm CABERGOLINE cabergoline TABLET;ORAL 076310 ANDA A-S Medication Solutions 50090-3951-0 8 TABLET in 1 BOTTLE (50090-3951-0) 2005-12-29
Pfizer DOSTINEX cabergoline TABLET;ORAL 020664 NDA AUTHORIZED GENERIC Greenstone LLC 59762-1005-1 8 TABLET in 1 BOTTLE (59762-1005-1) 2014-09-22
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Colorcon
Moodys
Baxter
Johnson and Johnson